애널리스트 14명 기준
목표가는 개별 리서치펌 단위가 아닌 시장 컨센서스(평균/최고/최저)입니다. 수집 액션 38건 · 최근 12개월 18건.
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 29. | Truist Securities | — | 의견 유지 | Buy → Buy | — | Truist Securities: Buy |
| 2026. 05. 28. | Barclays | — | 커버리지 개시 | — → Overweight | — | Barclays: Overweight |
| 2026. 05. 16. | Leerink Partners | — | 의견 유지 | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2026. 05. 13. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 05. | Craig-Hallum | — | 의견 유지 | Buy → Buy | — | Craig-Hallum: Buy |
| 2026. 03. 04. | Stephens & Co. | — | 의견 유지 | Overweight → Overweight | — | Stephens & Co.: Overweight |
| 2026. 02. 12. | HC Wainwright & Co. | — | 커버리지 개시 | — → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 01. 15. | Wedbush | — | 의견 유지 | Outperform → Outperform | — | Wedbush: Outperform |
| 2025. 12. 17. | Lake Street | — | 의견 유지 | Buy → Buy | — | Lake Street: Buy |
| 2025. 12. 16. | Evercore ISI Group | — | 의견 유지 | Outperform → Outperform | — | Evercore ISI Group: Outperform |
| 2025. 12. 16. | Guggenheim | — | 의견 유지 | Buy → Buy | — | Guggenheim: Buy |
| 2025. 12. 01. | Truist Securities | — | 커버리지 개시 | — → Buy | — | Truist Securities: Buy |
| 2025. 11. 17. | Stephens & Co. | — | 의견 유지 | Overweight → Overweight | — | Stephens & Co.: Overweight |
| 2025. 09. 22. | Goldman Sachs | — | 커버리지 개시 | — → Buy | — | Goldman Sachs: Buy |
| 2025. 09. 05. | Craig-Hallum | — | 커버리지 개시 | — → Buy | — | Craig-Hallum: Buy |
| 2025. 08. 25. | Guggenheim | — | 의견 유지 | Buy → Buy | — | Guggenheim: Buy |
| 2025. 08. 23. | Evercore ISI Group | — | 커버리지 개시 | — → Outperform | — | Evercore ISI Group: Outperform |
| 2025. 08. 08. | JP Morgan | — | 의견 유지 | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 04. 02. | Lake Street | — | 커버리지 개시 | — → Buy | — | Lake Street: Buy |
| 2025. 03. 20. | Wedbush | — | 의견 유지 | Outperform → Outperform | — | Wedbush: Outperform |
| 2025. 03. 20. | Stephens & Co. | — | 의견 유지 | Overweight → Overweight | — | Stephens & Co.: Overweight |
| 2025. 03. 20. | Guggenheim | — | 의견 유지 | Buy → Buy | — | Guggenheim: Buy |
| 2025. 03. 11. | LifeSci Capital | — | 커버리지 개시 | — → Outperform | — | LifeSci Capital: Outperform |
| 2024. 11. 14. | Piper Sandler | — | 의견 유지 | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2024. 11. 08. | Stephens & Co. | — | 커버리지 개시 | — → Overweight | — | Stephens & Co.: Overweight |
| 2024. 10. 26. | Wedbush | — | 의견 유지 | Outperform → Outperform | — | Wedbush: Outperform |
| 2024. 08. 13. | Wedbush | — | 의견 유지 | Outperform → Outperform | — | Wedbush: Outperform |
| 2024. 08. 13. | Piper Sandler | — | 의견 유지 | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2024. 05. 31. | Piper Sandler | — | 커버리지 개시 | — → Overweight | — | Piper Sandler: Overweight |
| 2024. 04. 30. | JP Morgan | — | 커버리지 개시 | — → Overweight | — | JP Morgan: Overweight |
| 2024. 04. 15. | Guggenheim | — | 커버리지 개시 | — → Buy | — | Guggenheim: Buy |
| 2024. 04. 01. | Wedbush | — | 의견 유지 | Outperform → Outperform | — | Wedbush: Outperform |
| 2024. 01. 23. | Wedbush | — | 의견 유지 | Outperform → Outperform | — | Wedbush: Outperform |
| 2023. 12. 19. | Wedbush | — | 커버리지 개시 | — → Outperform | — | Wedbush: Outperform |
| 2023. 03. 20. | Cantor Fitzgerald | — | 의견 유지 | — → Overweight | — | Cantor Fitzgerald: Overweight |
| 2023. 03. 17. | Chardan Capital | — | 의견 유지 | — → Buy | — | Chardan Capital: Buy |
| 2021. 10. 29. | Cantor Fitzgerald | — | 커버리지 개시 | — → Overweight | — | Cantor Fitzgerald: Overweight |
| 2020. 10. 27. | Chardan Capital | — | 커버리지 개시 | — → Buy | — | Chardan Capital: Buy |